Pathophysiology  ||| S:0 E:16 ||| NNP
and  ||| S:16 E:20 ||| CC
pathogenesis  ||| S:20 E:33 ||| NN
of  ||| S:33 E:36 ||| IN
immune-mediated  ||| S:36 E:52 ||| JJ
inflammatory  ||| S:52 E:65 ||| JJ
diseases ||| S:65 E:73 ||| NNS
:  ||| S:73 E:75 ||| :
commonalities  ||| S:75 E:89 ||| NNS
and  ||| S:89 E:93 ||| CC
differences  ||| S:93 E:105 ||| NNS
Immune-mediated  ||| S:105 E:121 ||| JJ
inflammatory  ||| S:121 E:134 ||| JJ
diseases  ||| S:134 E:143 ||| NNS
( ||| S:143 E:144 ||| -LRB-
IMID ||| S:144 E:148 ||| NNP
)  ||| S:148 E:150 ||| -RRB-
represent  ||| S:150 E:160 ||| VBP
a  ||| S:160 E:162 ||| DT
diverse  ||| S:162 E:170 ||| JJ
group  ||| S:170 E:176 ||| NN
of  ||| S:176 E:179 ||| IN
chronic  ||| S:179 E:187 ||| JJ
conditions  ||| S:187 E:198 ||| NNS
that  ||| S:198 E:203 ||| IN
share  ||| S:203 E:209 ||| NN
common  ||| S:209 E:216 ||| JJ
pathways ||| S:216 E:224 ||| NN
.  ||| S:224 E:226 ||| .
Although  ||| S:226 E:235 ||| IN
the  ||| S:235 E:239 ||| DT
etiology  ||| S:239 E:248 ||| NN
of  ||| S:248 E:251 ||| IN
IMID  ||| S:251 E:256 ||| NNP
has  ||| S:256 E:260 ||| VBZ
yet  ||| S:260 E:264 ||| RB
to  ||| S:264 E:267 ||| TO
be  ||| S:267 E:270 ||| VB
identified ||| S:270 E:280 ||| VBN
,  ||| S:280 E:282 ||| ,
it  ||| S:282 E:285 ||| PRP
is  ||| S:285 E:288 ||| VBZ
well  ||| S:288 E:293 ||| RB
known  ||| S:293 E:299 ||| VBN
that  ||| S:299 E:304 ||| IN
both  ||| S:304 E:309 ||| DT
genetic  ||| S:309 E:317 ||| JJ
and  ||| S:317 E:321 ||| CC
environmental  ||| S:321 E:335 ||| JJ
factors  ||| S:335 E:343 ||| NNS
play  ||| S:343 E:348 ||| VBP
an  ||| S:348 E:351 ||| DT
important  ||| S:351 E:361 ||| JJ
role  ||| S:361 E:366 ||| NN
in  ||| S:366 E:369 ||| IN
the  ||| S:369 E:373 ||| DT
development  ||| S:373 E:385 ||| NN
of  ||| S:385 E:388 ||| IN
these  ||| S:388 E:394 ||| DT
disorders ||| S:394 E:403 ||| NNS
.  ||| S:403 E:405 ||| .
Genome-wide  ||| S:405 E:417 ||| JJ
association  ||| S:417 E:429 ||| NN
( ||| S:429 E:430 ||| -LRB-
GWA ||| S:430 E:433 ||| NNP
)  ||| S:433 E:435 ||| -RRB-
studies  ||| S:435 E:443 ||| NNS
and  ||| S:443 E:447 ||| CC
GW  ||| S:447 E:450 ||| NNP
nonsynonymous  ||| S:450 E:464 ||| FW
single-nucleotide  ||| S:464 E:482 ||| FW
polymorphism  ||| S:482 E:495 ||| FW
( ||| S:495 E:496 ||| -LRB-
nsSNP ||| S:496 E:501 ||| NNP
)  ||| S:501 E:503 ||| -RRB-
scans  ||| S:503 E:509 ||| NNS
have  ||| S:509 E:514 ||| VBP
recently  ||| S:514 E:523 ||| RB
led  ||| S:523 E:527 ||| VBN
to  ||| S:527 E:530 ||| TO
identification  ||| S:530 E:545 ||| VB
of  ||| S:545 E:548 ||| IN
genes  ||| S:548 E:554 ||| NNS
commonly  ||| S:554 E:563 ||| RB
found  ||| S:563 E:569 ||| VBN
in  ||| S:569 E:572 ||| IN
several  ||| S:572 E:580 ||| JJ
different  ||| S:580 E:590 ||| JJ
IMID  ||| S:590 E:595 ||| NN
as  ||| S:595 E:598 ||| IN
well  ||| S:598 E:603 ||| RB
as  ||| S:603 E:606 ||| IN
those  ||| S:606 E:612 ||| DT
that  ||| S:612 E:617 ||| WDT
are  ||| S:617 E:621 ||| VBP
disease-specific ||| S:621 E:637 ||| JJ
.  ||| S:637 E:639 ||| .
Current  ||| S:639 E:647 ||| JJ
epidemiological ||| S:647 E:662 ||| NN
,  ||| S:662 E:664 ||| ,
clinical ||| S:664 E:672 ||| JJ
,  ||| S:672 E:674 ||| ,
and  ||| S:674 E:678 ||| CC
experimental  ||| S:678 E:691 ||| JJ
evidence  ||| S:691 E:700 ||| NN
has  ||| S:700 E:704 ||| VBZ
also  ||| S:704 E:709 ||| RB
confirmed  ||| S:709 E:719 ||| VBD
an  ||| S:719 E:722 ||| DT
association  ||| S:722 E:734 ||| NN
between  ||| S:734 E:742 ||| IN
IMID  ||| S:742 E:747 ||| NNP
and  ||| S:747 E:751 ||| CC
a  ||| S:751 E:753 ||| DT
large  ||| S:753 E:759 ||| JJ
number  ||| S:759 E:766 ||| NN
of  ||| S:766 E:769 ||| IN
seemingly  ||| S:769 E:779 ||| RB
unrelated  ||| S:779 E:789 ||| JJ
environmental  ||| S:789 E:803 ||| JJ
factors ||| S:803 E:810 ||| NNS
,  ||| S:810 E:812 ||| ,
which  ||| S:812 E:818 ||| WDT
include  ||| S:818 E:826 ||| VBP
smoking ||| S:826 E:833 ||| NN
,  ||| S:833 E:835 ||| ,
diet ||| S:835 E:839 ||| NN
,  ||| S:839 E:841 ||| ,
drugs ||| S:841 E:846 ||| NNS
,  ||| S:846 E:848 ||| ,
geographical  ||| S:848 E:861 ||| NN
and  ||| S:861 E:865 ||| CC
social  ||| S:865 E:872 ||| JJ
status ||| S:872 E:878 ||| NN
,  ||| S:878 E:880 ||| ,
stress ||| S:880 E:886 ||| NN
,  ||| S:886 E:888 ||| ,
and  ||| S:888 E:892 ||| CC
microbial  ||| S:892 E:902 ||| JJ
agents ||| S:902 E:908 ||| NNS
.  ||| S:908 E:910 ||| .
Data  ||| S:910 E:915 ||| NNS
supporting  ||| S:915 E:926 ||| VBG
the  ||| S:926 E:930 ||| DT
involvement  ||| S:930 E:942 ||| NN
of  ||| S:942 E:945 ||| IN
each  ||| S:945 E:950 ||| DT
of  ||| S:950 E:953 ||| IN
these  ||| S:953 E:959 ||| DT
factors  ||| S:959 E:967 ||| NNS
in  ||| S:967 E:970 ||| IN
predisposing  ||| S:970 E:983 ||| VBG
to ||| S:983 E:985 ||| TO
,  ||| S:985 E:987 ||| ,
triggering ||| S:987 E:997 ||| VBG
,  ||| S:997 E:999 ||| ,
or  ||| S:999 E:1002 ||| CC
modulating  ||| S:1002 E:1013 ||| VBG
the  ||| S:1013 E:1017 ||| DT
course  ||| S:1017 E:1024 ||| NN
or  ||| S:1024 E:1027 ||| CC
outcome  ||| S:1027 E:1035 ||| NN
of  ||| S:1035 E:1038 ||| IN
IMID  ||| S:1038 E:1043 ||| NNP
vary  ||| S:1043 E:1048 ||| VBP
from  ||| S:1048 E:1053 ||| IN
strong  ||| S:1053 E:1060 ||| JJ
to  ||| S:1060 E:1063 ||| TO
tenuous ||| S:1063 E:1070 ||| VB
.  ||| S:1070 E:1072 ||| .
The  ||| S:1072 E:1076 ||| DT
notion  ||| S:1076 E:1083 ||| NN
of  ||| S:1083 E:1086 ||| IN
shared  ||| S:1086 E:1093 ||| VBN
genetic  ||| S:1093 E:1101 ||| JJ
pathways  ||| S:1101 E:1110 ||| NN
creates  ||| S:1110 E:1118 ||| VBZ
new  ||| S:1118 E:1122 ||| JJ
and  ||| S:1122 E:1126 ||| CC
powerful  ||| S:1126 E:1135 ||| JJ
approaches  ||| S:1135 E:1146 ||| NNS
for  ||| S:1146 E:1150 ||| IN
discovering  ||| S:1150 E:1162 ||| VBG
the  ||| S:1162 E:1166 ||| DT
full  ||| S:1166 E:1171 ||| JJ
spectrum  ||| S:1171 E:1180 ||| NN
and  ||| S:1180 E:1184 ||| CC
potential  ||| S:1184 E:1194 ||| JJ
of  ||| S:1194 E:1197 ||| IN
susceptible  ||| S:1197 E:1209 ||| JJ
genes  ||| S:1209 E:1215 ||| NNS
in  ||| S:1215 E:1218 ||| IN
these  ||| S:1218 E:1224 ||| DT
potentially  ||| S:1224 E:1236 ||| RB
disabling  ||| S:1236 E:1246 ||| VBG
chronic  ||| S:1246 E:1254 ||| JJ
conditions ||| S:1254 E:1264 ||| NNS
.  ||| S:1264 E:1266 ||| .
Insights  ||| S:1266 E:1275 ||| NNS
relating  ||| S:1275 E:1284 ||| VBG
to  ||| S:1284 E:1287 ||| TO
a  ||| S:1287 E:1289 ||| DT
specific  ||| S:1289 E:1298 ||| JJ
immune  ||| S:1298 E:1305 ||| JJ
pathway  ||| S:1305 E:1313 ||| NN
could  ||| S:1313 E:1319 ||| MD
provide  ||| S:1319 E:1327 ||| VB
targets  ||| S:1327 E:1335 ||| NNS
for  ||| S:1335 E:1339 ||| IN
therapeutic  ||| S:1339 E:1351 ||| JJ
interventions ||| S:1351 E:1364 ||| NNS
.  ||| S:1364 E:1366 ||| .
